SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-261313
Filing Date
2013-06-17
Accepted
2013-06-17 16:26:21
Documents
7
Period of Report
2013-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d553948d8k.htm 8-K 25362
2 EX-1.1 d553948dex11.htm EX-1.1 167390
3 EX-5.1 d553948dex51.htm EX-5.1 6709
4 EX-5.2 d553948dex52.htm EX-5.2 6698
5 EX-99.1 d553948dex991.htm EX-99.1 6593
6 EX-99.2 d553948dex992.htm EX-99.2 6734
7 EX-99.3 d553948dex993.htm EX-99.3 6574
  Complete submission text file 0001193125-13-261313.txt   227215
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 13917075
SIC: 2834 Pharmaceutical Preparations